Neoadjuvant Sequencing
Neoadjuvant Sequencing is a strategic treatment protocol in oncology that refers to the administration of immunotherapeutic agents before surgical intervention to modulate the tumor microenvironment and enhance systemic immune responses, thereby distinguishing it from adjuvant approaches that follow surgery.
17
Publications
973
Citations
288
Authors
106
Institutions
Publications per year
2017–2026
10
Parents
17
Ingeborg Tinhofer, Volker Budach, Mohammad Saki et al. · European Journal of Cancer · 2016 · 67 citations
1–5 of 17
288
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 288
106
The University of Texas MD Anderson Cancer Center
Houston, United States
2 h-index
11 publications
207 citations
Heidelberg University
Heidelberg, Germany
2 h-index
25 publications
2K citations

University Hospital Heidelberg
Heidelberg, Germany
2 h-index
3 publications
547 citations
Charité - Universitätsmedizin Berlin
Berlin, Germany
2 h-index
8 publications
487 citations
University of California, San Francisco
San Francisco, United States
2 h-index
2 publications
431 citations

University of Tübingen
Tübingen, Germany
2 h-index
3 publications
161 citations
Ludwig-Maximilians-Universität München
Munich, Germany
2 h-index
3 publications
121 citations
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, United States
2 h-index
3 publications
66 citations
1–8 of 106
1 publications · 413 citations
1
h-index
1 publications · 83 citations
1
h-index
1 publications · 70 citations
1
h-index
Repository · 1 publications · 69 citations
1
h-index
1 publications · 67 citations
1
h-index
1–5